Rigel Reports First Quarter 2026 Financial Results
Go back to Rigel Reports First Quarter 2026 Financial Results| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 40.17 +0.95 (2.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.22 | 52 Week High | $4.38 | |||
| Open | $39.55 | 52 Week Low | $1.88 | |||
| Day High | $41.13 | P/E | N/A | |||
| Day Low | $39.51 | EPS | $-1.12 | |||
| Volume | 315,510 | |||||
